New research has assessed a genetically engineered fungus for the control of malaria mosquitoes in the first semi-field trial, demonstrating that populations were reduced by more than 99%.
Take a look at this month’s industry headlines including US FDA approvals for Mavyret (hepatitis C) and Dengvaxia, a rejection for Contepo and profits for Gilead Sciences.
Over 800,000 individuals will be vaccinated against cholera in North Kivu, Democratic Republic of Congo, as the area suffers an unprecedented combination of epidemics.
A cohort of scientists from the Wellcome Sanger Institute, the University of Cambridge, the Peter Doherty Institute for Infection and Immunity and the University of Queensland have identified novel targets using DNA sequencing, bringing research one step closer to developing a universal vaccine against Group A Streptococcus.
Early antiretroviral treatment in people with HIV infection could allow the generation of more functional and persistent CD8 T cell responses. The results, which suggest a long-term immune memory, could have implications for HIV vaccine development.
Argentina and Algeria have officially been certified as free of malaria by the WHO, both becoming the second country in their respective regions to achieve this certification.
New research has identified four novel sepsis phenotypes, suggesting these could be relevant for understanding the heterogeneity of treatment effects and help to explain recent clinical trial failures.
Scientists have created the world’s first living organism that has a synthetic and altered genetic code, built on only 61 codons as opposed to 64.
Giving a single dose of preventative antibiotics after assisted childbirth could prevent almost half of maternal infections and also reduce antibiotic use by infection prevention, according to a new trial.
A new anaerobic organ-on-a-chip model has been demonstrated to support a complex community of gut microbes under low-oxygen conditions. This model of the microbiome could open opportunities for drug testing and development.